Syngeneic Subcutaneous Melanoma with CPI Treatment – Germ Free

Description

Differential response to syngeneic tumor growth can be observed in germ-free animals relative to those with an endogenous microbiome. Evaluation of tumor growth and checkpoint inhibitor sensitivity in germ-free mice enables assessment of phenotypes’ dependency on a constitutive microbiome, whether due to the microbiome itself or due to other immunological effects. Data from a syngeneic subcutaneous melanoma model induced in germ-free mice is shown.

Model Systems
  • C57Bl/6 Mice
Standard Readouts
  • Tumor measurement
  • Body condition scoring
Additional Readouts
  • Assessment of bacteria load (culture and qPCR)
  • Sequencing and metagenomics
  • Peripheral lymphoid organ immunophenotyping (Flow Cytometry)
  • Tumor infiltrating lymphocyte immunophenotyping (Flow Cytometry)
  • Custom assays
Representative DataClick Image to Enlarge
Tumor Growth in a Syngeneic Subcutaneous Melanoma Model in Germ-Free Mice

Tumor-inoculated animals undergo tumor measurement 2-3 times per week and tumor volume is calculated. The AUC is calculated to compare treatment arms and is shown in the inset. (*p<0.01).

Daniel Lichtman

Managing Partner